The chequered history of the antiphospholipid syndrome

British Journal of Haematology

Volumn 165, Issue 5, 2014, Pages 609-617

  Jayakody Arachchillage, Deepa ^a   Greaves, Mike ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anticardiolipin; Antiphospholipid syndrome; History of medicine; Lupus anticoagulant; Thrombosis

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYLSALICYLIC ACID; ANTIVITAMIN K; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; COMPLEMENT INHIBITOR; CORTICOSTEROID; ECULIZUMAB; FLUINDOSTATIN; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RITUXIMAB; THROMBOPLASTIN; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMMUNOASSAY; IMMUNOPATHOGENESIS; LIPID ANALYSIS; NONHUMAN; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTHROMBIN TIME; REVIEW; RHEUMATOID ARTHRITIS; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TREATMENT PLANNING; VENOUS THROMBOEMBOLISM; ABORTION, HABITUAL; BLOOD; COMPLICATION; FEMALE; HISTORY; PREGNANCY; SYPHILIS SEROLOGY;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; CARDIOLIPINS; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LUPUS COAGULATION INHIBITOR; PREGNANCY; SYPHILIS SERODIAGNOSIS; THROMBOSIS;

EID: 84900505972     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12848     Document Type: Review

References (91)

1. Aggeler, P.M., Lindsay, S. & Lucia, S.P. (1946) Studies on the coagulation defect in a case of thrombocytopenic purpura complicated by thrombosis. American Journal of Pathology, 22, 1181-1203.
2. Alarcon-Segovia, D. & Sanchez-Guerrero, A. (1989) Primary antiphospholipid syndrome. The Journal of Rheumatology, 16, 482-488.
3. Amengual, O., Atsumi, T., Khamashta, M.A. & Hughes, G.R. (1998) The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thrombosis and Haemostasis, 79, 276-281.
4. Asherson, R.A. (1988) A "primary" antiphospholipid syndrome? The Journal of Rheumatology, 15, 1742-1746.
5. Asherson, R.A. (1992) The catastrophic antiphospholipid syndrome. The Journal of Rheumatology, 19, 508-512.
6. Bingley, P.J. & Hoffbrand, B.I. (1987) Antiphospholipid antibody syndrome: a review. Journal of the Royal Society of Medicine, 80, 445-448.
7. Bird, A.G., Lendrum, R., Asherson, R.A. & Hughes, G.R.V. (1987) Disseminated intravascular coagulation, antiphospholipid antibodies and ischemic necrosis of the extremities. Annals of the Rheumatic Diseases, 56, 568-570.
8. Blank, M., Cohen, J., Toder, V. & Shoenfeld, Y. (1991) Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proceedings of the National Academy of Sciences of the USA, 88, 3069-3073.
9. Boey, M.L., Colaco, C.B., Gharavi, A.E., Elkon, K.B., Loizou, S. & Hughes, G.R. (1983) Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. British Medical Journal (Clinical Research Ed), 287, 1021-1023.
10. Bowie, E.J., Thompson, J.H. Jr, Pascuzzi, C.A. & Owen, C.A. Jr (1963) Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. Journal of Laboratory and Clinical Medicine, 62, 416-430.
11. Branch, D.W. & Rodgers, G.M. (1993) Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. American Journal of Obstetrics and Gynecology, 168, 206-210.
12. Branch, D.W., Dudley, D.J., Mitchell, M.D., Creighton, K.A., Abbott, T.M., Hammond, E.H. & Daynes, R.A. (1990) Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune featal loss. American Journal of Obstertrics and Gynecology, 163, 210-216.
13. Carter, A.E., Eban, R. & Perrett, R.D. (1971) Prevention of post-operative deep venous thrombosis and pulmonary embolism. British Medical Journal, 1, 312-314.
14. Conley, C. & Hartmann, R.C. (1952) A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. Journal of Clinical Investigation, 31, 2.
15. Crowther, M.A., Ginsberg, J.S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M. & Kovacs, M.J. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. New England Journal of Medicine, 349, 1133-1138.
16. Erkan, D. & Lockshin, M.D. (2012) ANTIPHOSPHOLIPID SYNDROME ACTION-AntiPhospholipid syndrome alliance for clinical trials and International Networking. Lupus, 21, 695-698.
17. Erkan, D., Harrison, M.J., Levy, R., Peterson, M., Petri, M., Sammaritano, L., Unalp-Arida, A., Vilela, V., Yazici, Y. & Lockshin, M.D. (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis and Rheumatism, 56, 2382-2391.
18. Erkan, D., Vega, J., Ramón, G., Kozora, E. & Lockshin, M.D. (2013) A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis and Rheumatism, 65, 464-471.
19. Ernst, E., Rose, M. & Lee, R. (1984) Modification of trans-operative changes in blood fluidity by hydroxy-chloroquine. A possible explanation for the drugs anti-thrombotic effect. Pharmatherapeutica, 4, 48-52.
20. Erre, G.L., Pardini, S., Faedda, R. & Passiu, G. (2008) Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature. Lupus, 17, 50-55.
21. Espinola, R.G., Pierangeli, S.S., Gharavi, A.E. & Harris, E.N. (2002) Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thrombosis and Haemostasis, 87, 518-522.
22. Espinosa, G., Berman, H. & Cervera, R. (2011) Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmunity Reviews, 10, 664-668.
23. Exner, T., Rickard, K.A. & Kronenberg, H. (1975) Studies on phospholipids in the action of a lupus coagulation inhibitor. Pathology, 7, 319-328.
24. Farquharson, R.G., Quenby, S. & Greaves, M. (2002) Antiphospholipid syndrome in pregnancy: a randomised controlled trial of treatment. Obstetrics and Gynecology, 100, 108-113.
25. Favaloro, E.J. & Silvestrini, R. (2002) Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. American Journal of Clinical Pathology, 118, 548-557.
26. Favaloro, E.J., Wong, R.C., Jovanovich, S. & Roberts-Thomson, P. (2007) A Review of beta2 -glycoprotein-l antibody testing results from a peer-driven multilaboratory quality assurance program. American Journal of Clinical Pathology, 127, 441-448.
27. Ferrara, D.E., Liu, X., Espinola, R.G., Meroni, P.L., Abukhalaf, I., Harris, E.N. & Pierangeli, S.S. (2003) Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model. Arthritis and Rheumatism, 48, 3272-3279.
28. Ferrara, D.E., Swerlick, R., Casper, K., Meroni, P.L., Vega-Ostertag, M.E., Harris, E.N. & Pierangeli, S.S. (2004) Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. Journal of Thrombosis and Haemostasis, 2, 1558-1563.
29. Finazzi, G. (2012) Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disorders. Lupus, 21, 747-750.
30. Finazzi, G., Brancaccio, V., Mola, M., Ciavarella, N., Mazzoconi, M.G., Schinco, P.C., Ruggeri, M., Pogliani, E.M., Gamba, G., Rossi, E., Baudo, F., Manotti, C., D'Angelo, A., Palaret, G., De Stefano, V., Berrettini, M. & Barbui, T. (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian Registry. The American Journal of Medicine, 100, 530-536.
31. Finazzi, G., Marchioli, R., Brancaccio, V., Schinco, P., Wisloff, F., Musial, J., Baudo, F., Berrettini, M., Testa, S., D'Angelo, A., Tognoni, G. & Barbui, T. (2005) A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis, 3, 848-853.
32. Firkin, B.G., Howard, M.A. & Radford, N. (1980) Possible relationship between lupus inhibitor and recurrent abortion in young women. The Lancet, 2, 366.
33. Frick, P.G. & Weimer, K. (1955) Acquired circulating anticoagulants in systemic collagen disease; auto-immune thromboplastin deficiency. Blood, 10, 691-706.
34. Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., de Baets, M.H., van Breda-Vriesman, P.J., Barbui, T., Zwaal, R.F. & Bevers, E.M. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. The Lancet, 335, 1544-1547.
35. Galli, M., Luciani, D., Bertolini, G. & Barbui, T. (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood, 101, 1827-1832.
36. Girardi, G., Redecha, P. & Salmon, J.E. (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nature Medicine, 10, 1222-1226.
37. Halcox, J.P. & Deanfield, J.E. (2004) Beyond the laboratory: clinical implications for statin pleiotropy. Circulation, 109, II42-II48.
38. Harris, E.N., Gharavi, A.E., Boey, M.L., Patel, B.M., Mackworth-Young, C.G., Loizou, S. & Hughes, G.R. (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. The Lancet, 2, 1211-1214.
39. Ingram, S.B., Goodnight, S.H. & Bennett, R.M. (1987) An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies. Report of two cases. Arthritis and Rheumatism, 30, 1167-1171.
40. Jajoria, P., Murthy, V., Papalardo, E., Romay-Penabad, Z., Gleason, C. & Pierangeli, S.S. (2009) Statins for the treatment of antiphospholipid syndrome? Annals of the New York Academy of Sciences, 1173, 736-745.
41. Jancinová, V., Nosál, R. & Petríková, M. (1994) On the inhibitory effect of chloroquine on blood platelet aggregation. Thrombosis Research, 74, 495-504.
42. Jennings, I., Greaves, M., Mackie, I.J., Kitchen, S., Woods, T.A. & Preston, F.E. (2002) Lupus 3anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. British Journal of Haematology, 119, 364-369.
43. Johnson, R. & Charnley, J. (1979) Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty. Clinical Orthopaedics and Related Research, 144, 174-177.
44. Kahn, R.L. (1924) The Kahn precipitation test for syphilis. American Journal of Public Health, 14, 498-507.
45. Keeling, D., Baglin, T., Tait, C., Watson, H., Perry, D., Baglin, C., Kitchen, S. & Makris, M. (2011) Guidelines on oral anticoagulation with warfarin - fourth edition. British Journal of Haematology, 154, 311-324.
46. Keeling, D., Mackie, I., Moore, G.W., Greer, I.A. & Greaves, M. (2012) Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology, 157, 47-58.
47. Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. & Hughes, G.R. (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. New England Journal of Medicine, 332, 993-997.
48. Knight, A. & Wilkinson, R.D. (1963) The clinical significance of the biological false positive serologic reactor: a study of 113 cases. Canadian Medical Association Journal, 88, 1193-1195.
49. Kuwana, M., Matsuura, E., Kobayashi, K., Okazaki, Y., Kaburaki, J., Ikeda, Y. & Kawakami, Y. (2005) Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. Blood, 105, 1552-1557.
50. de Laat, H.B., Derksen, R.H., Urbanus, R.T., Roest, M. & de Groot, P.G. (2004) IgGantibodies that recognize epitope Gly40-Arg43 in domain I of beta2 glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood, 105, 1540-1545.
51. Laskin, C.A., Bombardier, C., Hannah, M.E., Mandel, F.P., Ritchie, J.W., Farewell, V., Farine, D., Spitzer, K., Fielding, L., Soloninka, C.A. & Yeung, M. (1997) Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. New England Journal of Medicine, 337, 148-153.
52. Laurell, A.B. & Nilsson, I.M. (1957) Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases. The Journal of Laboratory and Clinical Medicine, 49, 694-707.
53. Levine, S.R., Brey, R.L., Tilley, B.C., Thompson, J.L., Sacco, R.L., Sciacca, R.R., Murphy, A., Lu, Y., Costigan, T.M., Rhine, C., Levin, B., Triplett, D.A. & Mohr, J.P. (2004) Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA, 291, 576-584.
54. Ley, A.B., Reader, G.G., Sorenson, C.W. & Overman, R.S. (1951) Idiopathic hypoprothrombinemia associated with hemorrhagic diathesis, and the effect of vitamin K. Blood, 6, 740-755.
55. Lim, W., Crowther, M.A. & Eikelboom, J.W. (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA, 295, 1050-1057.
56. Lonze, B.E., Singer, A.L. & Montgomery, R.A. (2010) Eculizumab and renal transplantation in a patient with CAPS. New England Journal of Medicine, 362, 1744-1745.
57. Lubbe, W.F. & Walker, E.B. (1983) Chorea gravidarum associated with circulating lupus anticoagulant: successful outcome of pregnancy with prednisone and aspirin therapy. Case report. British Journal of Obstetrics and Gynaecology, 90, 487-490.
58. Lubinski, H.H. (1947) Interpretation and significance of false positive serological reactions for syphilis. Canadian Medical Association Journal, 57, 33-35.
59. Madow, B.P. (1960) Use of antimalarial drugs as "desludging" agents in vascular disease processes. Journal of the American Medical Association, 172, 1630-1633.
60. Manoharan, A., Gibson, L., Rush, B. & Feery, B.J. (1977) Recurrent venous thrombosis with a "lupus" coagulation inhibitor in the absence of systemic lupus. Australia and New Zealand Journal of Medicine, 7, 422-426.
61. Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K. & Koike, T. (1990) Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. The Lancet, 336, 177-178.
62. McNeil, H.P., Simpson, R.J., Chesterman, C.N. & Krilis, S.A. (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proceedings of the National Academy of Sciences of the USA, 87, 4120-4124.
63. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., de Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306.
64. Molina, A. (2008) A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma. Annual Reviews of Medicine, 59, 237-250.
65. Moore, J.E. & Mohr, C.F. (1952) Biologically false positive serologic tests for syphilis; type, incidence, and cause. Journal of the American Medical Association, 150, 467-473.
66. Nelson, R.A. & Mayer, M.M. (1949) Immobilisation of Treponema pallidum in vitro by antibody produced in syphilitic infection. The Journal of Experimental Medicine, 89, 369-393.
67. Pangborn, M.C. (1941) A new serologically active phospholipid from beef heart. Proceedings of the Society of Experimental Biology (NY), 48, 484-486.
68. Pengo, V., Biasiolo, A., Gresele, P., Marongiu, F., Erba, N., Veschi, F., Ghirarduzzi, A., de Candia, E., Montaruli, B., Testa, S., Barcellona, D. & Tripodi, A. (2007) Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. Journal of Thrombosis and Haemostasis, 5, 925-930.
69. Pengo, V., Ruffatti, A., Legnani, C., Gresele, P., Barcellona, D., Erba, N., Testa, S., Marongiu, F., Bison, E., Denas, G., Banzato, A., Padayattil, J.S. & Iliceto, S. (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. Journal of Thrombosis and Haemostasis, 8, 237-242.
70. Pengo, V., Ruffatti, A., Legnani, C., Testa, S., Fierro, T., Marongiu, F., de Micheli, V., Gresele, P., Tonello, M., Ghirarduzzi, A., Bison, E., Denas, G., Banzato, A., Padayattil, J.S. & Iliceto, S. (2011) Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood, 118, 4714-4718.
71. Petri, M. (2011) Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients. Current Rheumatology Reports, 13, 77-80.
72. Rai, R.S., Clifford, K., Cohen, H. & Regan, L. (1995) High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Human Reproduction, 10, 3301-3304.
73. Rai, R., Cohen, H., Dave, M. & Regan, L. (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). British Medical Journal, 314, 253-257.
74. Rand, J.H., Wu, X.X., Andree, H.A., Lockwood, C.J., Guller, S., Scher, J. & Harpel, P.C. (1997a) Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. New England Journal of Medicine, 337, 154-160.
75. Rand, J.H., Wu, X.X., Guller, S., Scher, J., Andree, H.A. & Lockwood, C.J. (1997b) Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. American Journal of Obstetrics and Gynecology, 177, 918-923.
76. Rand, J.H., Wu, X.X., Andree, H.A., Ross, J.B., Rusinova, E., Gascon-Lema, M.G., Calandri, C. & Harpel, P.C. (1998) Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood, 92, 1652-1660.
77. Rao, L.V., Hoang, A.D. & Rapaport, S.I. (1996) Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid. Blood, 88, 4173-4182.
78. Robertson, B. & Greaves, M. (2006) Antiphospholipid syndrome: an evolving story. Blood Reviews, 20, 201-212.
79. Rosove, M.H. & Brewer, P.M. (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Annals of Internal Medicine, 117, 303-308.
80. Ruffatti, A., Del Ross, T., Ciprian, M., Bertero, M.T., Sciascia, S., Scarpato, S., Montecucco, C., Rossi, S., Caramaschi, P., Biasi, D., Doria, A., Rampudda, M., Monica, N., Fischetti, F., Picillo, U., Brucato, A., Salvan, E., Vittorio, P., Meroni, P. & Tincani, A. (2011) Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Annals of the Rheumatic Diseases, 70, 1083-1086.
81. Ruiz-Irastorza, G., Hunt, B.J. & Khamashta, M.A. (2007) A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis and Rheumatism, 57, 1487-1495.
82. Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P. & Khamashta, M.A. (2010) Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Annals of the Rheumatic Diseases, 69, 20-28.
83. Ruiz-Irastorza, G., Cuadrado, M.J., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R., Erkan, D., Krilis, S., Machin, S., Pengo, V., Pierangeli, S., Tektonidou, M. & Khamashta, M. (2011) Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus, 20, 206-218.
84. Santiago, M., Martinelli, R., Ko, A., Reis, E.A., Fontes, R.D., Nascimento, E.G., Pierangeli, S., Espinola, R. & Gharavi, A. (2001) Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clinical and Experimental Rheumatology, 19, 425-430.
85. Shapira, I., Andrade, D., Allen, S.L. & Salmon, J.E. (2012) Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Arthritis and Rheumatism, 64, 2719-2723.
86. Terrier, B., Amoura, Z., Ravaud, P., Hachulla, E., Jouenne, R., Combe, B., Bonnet, C., Cacoub, P., Cantagrel, A., de Bandt, M., Fain, O., Fautrel, B., Gaudin, P., Godeau, B., Harle, J.R., Hot, A., Kahn, J.E., Lambotte, O., Larroche, C., Leone, J., Meyer, O., Pallot-Prades, B., Pertuiset, E., Quartier, P., Schaerverbeke, T., Sibilia, J., Somogyi, A., Soubrier, M., Vignon, E., Bader-Meunier, B., Mariette, X. & Gottenberg, J.E. (2010) Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis and Rheumatism, 62, 2458-2466.
87. Thiagarajan, P., Pengo, V. & Shapiro, S.S. (1986) The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood, 68, 869-874.
88. Triolo, G., Ferrante, A., Ciccia, F., Accardo-Palumbo, A., Perino, A., Castelli, A., Giarratano, A. & Licata, G. (2003) Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis and Rheumatism, 48, 728-731.
89. Wasserman, A., Neisser, A. & Bruck, C. (1906) Eine serodiagnostiche reaktion bei syphilis. Deutscher Medizinische. Wochenschrift, 32, 745-746.
90. Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J.C., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R., Triplett, D.A. & Khamashta, M.A. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism, 42, 1309-1311.
91. Yin, E.T. & Gaston, L.W. (1965) Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. Thrombosis and Diathesis Haemorrhagica, 14, 88-115.